NPC cells were treated with Rapamycin, an autophagy activator, to verify whether the activation of autophagy can reverse the radiosensitivity induced by silencing VEGF through clonogenic and CCK-8 assays. This evidence concerns the gene VEGFA and nasopharyngeal carcinoma.